![]() |
市场调查报告书
商品编码
1755963
2032 年外用药物包装市场预测:按产品类型、性质、包装材料、剂型、最终用户和地区进行的全球分析Topical Drugs Packaging Market Forecasts to 2032 - Global Analysis By Product Type (Plastic Bottles, Caps & Closures, Inhalers, Plastic Tubes, Glass Bottles), Nature, Packaging Material, Mode of Administration, End User and By Geography |
根据 Stratistics MRC 的数据,全球外用药物包装市场预计在 2025 年达到 55 亿美元,到 2032 年将达到 104 亿美元,预测期内的复合年增长率为 9.4%。
外用药物包装是指专为用于皮肤或黏膜给药而设计的容器和给药系统。这些容器包括管、瓶、帮浦和贴剂,旨在保护药物稳定性、确保剂量精准并防止污染。包装材料的选择应与活性成分相容,并提供阻隔水分、光线和空气的屏障,以保持药物的功效和保质期。
根据世界卫生组织 (WHO) 的数据,全球约有 23 亿人患有皮肤病,因此对高效包装以便于使用的皮肤病治疗药物的需求日益增长。
先进封装技术
包装技术的进步是外用药物包装市场的关键驱动力。材料、分配机制和阻隔性能的创新正在提升产品的安全性、功效和使用者便利性。新的包装解决方案能够更好地防止污染、防潮和避光,并延长保质期。包装设计的不断发展增强了外用药物製剂的保护性和易用性。在追求卓越产品完整性的驱动下,技术进步是包装创新的驱动力。
材料相容性成本高
高昂的材料相容性成本是外用药物包装市场的一个显着限制因素。外用药物由于其活性药物成分 (API) 和辅料的特性,可能与某些包装材料发生不良反应,导致药效降低或改变。需要进行广泛的测试,以确保包装材料不会渗入产品或吸附活性成分,这既昂贵又耗时。如此严格的兼容性评估会产生大量的开发成本。严格的材料相容性要求背后的成本仍然是一项重大挑战。
个性化医疗的发展
个人化医疗的成长为外用药物包装市场带来了巨大的机会。随着治疗方案越来越贴合每位患者的个别情况,外用製剂对灵活、小批量、客製化包装解决方案的需求日益增长。这包括单剂量包装、专用施用器以及可容纳不同剂量的包装。精准医疗格局的不断发展为包装创新开闢了新的途径。在个人化医疗客製化需求的推动下,新的包装解决方案正在出现。
仿冒药品包装
假药包装对外用药包装市场构成重大威胁。假冒外用药的增多,通常含有不合格或有害成分,直接影响病人安全和品牌声誉。造假者常使用模仿正品的包装,使消费者难以区分仿冒品。保护供应链和确保产品真实性是该行业面临的关键挑战。面对猖獗的假威胁,安全包装至关重要。
新冠疫情对外用药物包装市场产生了多方面的影响。人们越来越关注个人卫生和外用防腐药物,而供应链中断则影响了某些包装材料的可得性。药品采购向电子商务的转变也增加了对用于直接面向消费者配送的坚固安全包装的需求。总体而言,市场已展现出应对不断变化的消费行为和物流挑战的适应能力。受供应链需求变化的触发,疫情再形成了包装的优先顺序。
预计塑胶瓶市场在预测期内将占据最大份额
市场占有率。由于其用途广泛且广受欢迎,塑胶瓶仍然是主要的包装形式。
预计在预测期内,液体部分将以最高的复合年增长率成长。
在预测期内,液体外用製剂(例如消毒剂、药用洗液和皮肤病治疗液)预计将达到最高成长。喷雾瓶和专用滴管等液体製剂包装技术的创新提高了其可用性。随着对便捷有效的液体外用製剂的需求不断增长,该细分市场预计将大幅增长。液体外用製剂应用范围的不断扩大正推动该细分市场实现显着增长。
预计亚太地区将在预测期内占据最大的市场占有率,这主要得益于该地区人口众多、医疗支出不断增长以及製药製造业的蓬勃发展。此外,当地製药公司和受託製造厂商的扩张也有助于推动该地区市场的发展。在蓬勃发展的製药业和庞大的消费群的支持下,亚太地区已在市场上占据领先地位。
预计北美地区在预测期内将呈现最高的复合年增长率。这得益于大型製药公司的布局、对新型药物输送系统研发的强劲投入以及先进包装解决方案的广泛采用。对专业化和个人化外用药物日益增长的需求进一步推动了市场扩张。此外,严格的药品包装监管规范也推动了技术创新和高品质材料的采用。在药品包装技术持续创新的推动下,北美市场可望迎来强劲成长。
According to Stratistics MRC, the Global Topical Drugs Packaging Market is accounted for $5.5 billion in 2025 and is expected to reach $10.4 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Topical drug packaging refers to specialized containers and delivery systems for medications applied to the skin or mucous membranes. These include tubes, bottles, pumps, or patches designed to protect the drug's stability, ensure precise dosing, and prevent contamination. Packaging materials are chosen for compatibility with active ingredients, providing barriers against moisture, light, and air to maintain efficacy and shelf life.
According to the World Health Organization (WHO), around 2.3 billion people globally suffer from skin diseases, thus contributing to the growing need for dermatological drugs that are packaged efficiently for ease of use.
Advancements in packaging technology
Advancements in packaging technology are a significant driver for the topical drugs packaging market. Innovations in materials, dispensing mechanisms, and barrier properties are enhancing product safety, efficacy, and user convenience. New packaging solutions offer improved protection against contamination, moisture, and light, extending shelf life. This continuous evolution in packaging design provides better protection and enhanced usability for topical drug formulations. Fueled by the pursuit of superior product integrity, technological advancements drive packaging innovation
High material compatibility costs
High material compatibility costs present a notable restraint for the topical drugs packaging market. Topical drugs, due to their active pharmaceutical ingredients (APIs) and excipients, can interact negatively with certain packaging materials, leading to degradation or altered efficacy. Extensive testing is required to ensure that packaging materials do not leach into the product or adsorb active ingredients, which can be costly and time-consuming. This rigorous compatibility assessment adds significant development costs. Backed by stringent material compatibility requirements, costs remain a significant challenge.
Growth in personalized medicine
Growth in personalized medicine represents a significant opportunity for the topical drugs packaging market. As treatments become more tailored to individual patients, there is a growing need for flexible, small-batch, and customized packaging solutions for topical formulations. This includes unit-dose packaging, specialized applicators, and packaging that can accommodate varying dosages. This evolving landscape of precision healthcare creates new avenues for packaging innovation. Propelled by the customization needs of personalized medicine, new packaging solutions emerge.
Counterfeit drug packaging
Counterfeit drug packaging poses a substantial threat to the topical drugs packaging market. The rise of counterfeit topical drugs, often with substandard or harmful ingredients, directly impacts patient safety and brand reputation. Counterfeiters often use packaging that mimics genuine products, making it difficult for consumers to distinguish between authentic and fake medications. Protecting the supply chain and ensuring product authenticity is a critical industry challenge. Influenced by the pervasive threat of counterfeiting, secure packaging is paramount.
The COVID-19 pandemic had a mixed impact on the topical drugs packaging market. While there was an increased focus on personal hygiene and antiseptic topical products, supply chain disruptions affected the availability of certain packaging materials. The shift towards e-commerce for pharmaceutical purchases also increased the demand for robust and secure packaging for direct-to-consumer delivery. Overall, the market demonstrated adaptability in response to changing consumer behavior and logistical challenges. Triggered by evolving supply chain demands, the pandemic reshaped packaging priorities.
The plastic bottles segment is expected to be the largest during the forecast period
The plastic bottles segment is expected to account for the largest market share during the forecast period, due to the versatility, cost-effectiveness, and barrier properties of plastic materials for packaging various topical drug formulations. Plastic bottles are widely used for creams, lotions, gels, and ointments, offering good protection against moisture and light. The ability to incorporate various dispensing closures, such as pumps and flip-tops, further solidifies their market leadership. Guided by their versatility and widespread acceptance, plastic bottles remain the leading packaging format.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate, driven by the increasing prevalence of liquid topical formulations, including antiseptic solutions, medicated washes, and dermatological solutions. Innovations in packaging for liquid formulations, such as spray bottles and specialized droppers, are enhancing their usability. As the demand for convenient and effective liquid topical medications grows, this segment is poised for significant acceleration. Spurred by expanding liquid topical applications, this segment is charting significant growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, primarily driven by the region's large population, increasing healthcare expenditure, and the growing pharmaceutical manufacturing sector. Furthermore, the expansion of local pharmaceutical companies and contract manufacturing organizations contributes to its market leadership. Backed by a thriving pharmaceutical industry and large consumer base, the Asia Pacific region secures its leading market position.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by the presence of major pharmaceutical companies, strong investment in research and development for novel drug delivery systems, and a high adoption rate of advanced packaging solutions. The increasing demand for specialized and personalized topical medications further drives market expansion. Furthermore, stringent regulatory standards for drug packaging encourage innovation and the adoption of high-quality materials. Motivated by continuous innovation in pharmaceutical packaging, North America is poised for robust market growth.
Key players in the market
Some of the key players in Topical Drugs Packaging Market include AptarGroup, Constantia Flexibles, Gerresheimer, ProAmpac, RPC Group, Crown Holdings, Huhtamaki, Amcor, West Pharmaceutical Services, Sappi, Sealed Air, Berry Global, Mundipharma, Sonoco Products, and Shelby.
In May 2025, AptarGroup's launched a smart topical drug dispenser with precise dosing technology. The system enhances patient compliance for dermatological treatments, integrating IoT for usage tracking and regulatory compliance.
In March 2025, Gerresheimer released customizable plastic tubes for topical drugs with tamper-evident features. The tubes enhance safety and usability, catering to the growing demand for personalized medicine packaging solutions.
In February 2025, Berry Global launched a liquid applicator for topical drugs, improving ease of use for patients. The design ensures precise delivery and compatibility with various formulations, supporting pharmaceutical innovation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.